Skip to Content

ALS (Amyotrophic Lateral Sclerosis), also known as Lou Gehrig’s disease, is a fatal incurable neurodegenerative disease. The disease usually strikes people between the ages of 40 and 70, and it’s estimated that as many as 30,000 Americans have the disease.1  It leads to progressive paralysis and typically results in death within 3-5 years. ALS progression is highly variable between patients, a fact which complicates drug development and clinical testing of new candidate therapies.

The most common way to measure ALS progression today is by ​using a subjective questionnaire called the ALS Functional Rating Scale ​(ALS-FRS)​. To complete the questionnaire, patients must reach a clinic with a trained ALS specialist and answer questions about their ability to speak, walk, breath, dress, and so on.  Unfortunately, this method is limited due to infrequent measurements, a challenging clinic visit for patients who often have limited mobility, the test is subjective and the data is not stored in a single repository.

SAP Architect, Meirav Daniel, and a team of volunteers from SAP Labs Israel, wanted to make a difference.  “We wanted to inspire people and show how mobile technology and cloud can revolutionize the course of a disease.”

Meirav Daniel. SAP Architect

Meirav and team worked with Prize4Life, a non-profit organization, and partner HP (Hewlett-Packard), and developed an app on SAP HANA Cloud platform called the ALS Mobile Analyzer. This mobile app enables caregivers to monitor patients daily in their own environment, then record and upload data on the patient’s condition. With the app, caregivers can immediately record how patients respond to stimuli. If there is any deterioration in their motor or mental skills, which are the main characteristics tracked as patients’ physical and mental conditions worsen gradually over time.  The app also records reactions or changes that are triggered by certain conditions like changes in activities, foods, and more.

This valuable data is collected using sensors.  In the future, this data will be analyzed by clinicians and doctors to monitor patients, respond quicker and serve as a basis for future research and development of new treatments. ​

SAP and our Partners. Improving Lives. That is our purpose.

To learn more, visit ALS Analyzer

Ashley Tully
Director, Global To-Partner Marketing

1: Source: UC San Diego School of Medicine

To report this post you need to login first.

Be the first to leave a comment

You must be Logged on to comment or reply to a post.

Leave a Reply